Related Experiment Video
Updated: Mar 19, 2026
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Celastrol Mitigates Acute Pancreatitis Associated Inflammation by Modulating the IL-34/CSF-1R Axis and Suppressing
Yang Yang1, Xiangli Ma1, Yujie Lin1
1Emergency Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou City, Gansu, 730030, People's Republic of China.
Background:
Acute pancreatitis (AP) is characterized by early acinar injury followed by rapid inflammatory amplification, yet the upstream molecular triggers linking tissue stress to cytokine escalation remain incompletely defined. Interleukin-34 (IL-34), a ligand of colony-stimulating factor-1 receptor (CSF-1R), regulates inflammatory signaling, but its role in AP has not been elucidated. Celastrol is a bioactive triterpenoid with established anti-inflammatory properties; however, whether it modulates IL-34-associated signaling in AP remains unclear.
Methods:
Experimental AP was induced in rats by retrograde sodium taurocholate infusion. Celastrol (6 mg/kg, i.p.) was administered 1 h prior to AP induction. In vitro, caerulein-stimulated AR42J acinar cells and IL-34 overexpressing cells were employed to evaluate functional relevance. ERK/NF-κB activation and inflammatory mediator production were assessed by Western blotting, ELISA, and immunofluorescence. Molecular docking was performed as an exploratory structural analysis of celastrol and the IL-34/CSF-1R complex.
Results:
Celastrol significantly attenuated pancreatic injury in vivo, reducing serum amylase activity by approximately 34% and improving histological scores (both P < 0.01). IL-34 protein expression was markedly increased in experimental AP (P < 0.001), accompanied by activation of CSF-1R-dependent ERK and NF-κB signaling. IL-34 overexpression enhanced inflammatory outputs, whereas celastrol suppressed IL-34 expression and downstream signaling activation (P < 0.05). Docking analysis suggested structural compatibility between celastrol and IL-34/CSF-1R. Targeting IL-34 signaling may represent a potential therapeutic approach for acute pancreatitis.
Conclusion:
These findings identify IL-34 as a previously unrecognized contributor to inflammatory amplification in experimental AP. Celastrol treatment was accompanied by reduced IL-34 expression and attenuation of ERK/NF-κB activation. Although further loss of function studies are required to establish direct causality, modulation of IL-34-related signaling may represent a potential therapeutic direction for AP.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...